External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home AHA 2026
Roche and Genentech at

AHA 2026

November 06 - November 09
Chicago, USA / Virtual (Hybrid)
professional.heart.org
We will be contributing to topics related to
Cardiovascular
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
07:45 PM
Duration 75mins Chicago, USA
Changes in CV Prognostic Markers of Central and Visceral Adiposity in Older and Younger Adults Living with Obesity/Overweight With ≥1 Weight-Related Comorbidity in a Phase 2 Trial of Enicepatide, a GLP-1/GIP Receptor Agonist
Odd Erik Johansen, Nikolaus Marx, Javed Butler, Helen M. Colhoun, Xuwei Hou, Julie H. Ishida, Macy Gipson, Ji (Emmy) Cheng
Cardiovascular - Metabolism | Obesity

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.